anifrolumab
astrazeneca
['lupus', 'anifro']
congress #acr22 | kenneth kalunian: long term safety &amp; efficacy from tulip-lte of anifrolumab (ani) vs pbo for #sle. aes were similar though deaths in all ani (0.6/100py) were higher than pbo (0.3/100py) &amp; ani resulted in &gt;imp in sledai-2k vs pbo which was maintained. #lupus 
An online resource, dedicated to providing information and up-to-date medical education within the lupus space.